Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;36(1):14-19.

Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans

Akshay Shetty  1 , Wing-Kin Syn  1
Affiliations

Health and Economic Burden of Nonalcoholic Fatty Liver Disease in the United States and Its Impact on Veterans

Akshay Shetty et al. Fed Pract. 2019 Jan.

Abstract

NAFLD is a leading cause of chronic liver disease and cirrhosis in the US and is associated with metabolic syndrome, type 2 diabetes, cardiovascular disease, and all-cause mortality.

PubMed Disclaimer

Conflict of interest statement

Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.

Figures

FIGURE 1
FIGURE 1
Spectrum of NAFLD Abbreviations: NAFL, nonalcoholic fatty liver; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; HCC, hepatocellular carcinoma. aFibrosis staging level. Wide spectrum of NAFLD includes simple steatosis (NAFL), steatohepatitis (NASH), NASH-fibrosis which may advance to cirrhosis. Complications of cirrhosis include HCC and decompensated liver disease (liver failure). Recent studies suggest that HCC also can arise in those without cirrhosis.
FIGURE 2
FIGURE 2
Burden of NAFLD Abbreviations: NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis. NAFLD affects up to 24% to 26% of Americans, with the majority having simple steatosis, while 20% to 30% of those with NAFLD have NASH. About 4% to 6% of those with NASH have cirrhosis.
FIGURE 3
FIGURE 3
Metabolic Conditions and Complications Associated With NAFLD Abbreviations: CKD, chronic kidney disease; CVD, cardiovascular disease; HLD, hyperlipidemia; HTN, hypertension; NAFLD, nonalcoholic fatty liver disease; OSA, obstructive sleep apnea; PCOS, polycystic ovary syndrome; T2DM, type 2 diabetes mellitus.
See this image and copyright information in PMC

References

    1. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212–1218. - PubMed
    1. Targher G, Bertolini L, Rodella S, et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444–450. - PubMed
    1. Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol. 2010;105(7):1567–1573. - PMC - PubMed
    1. Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686–690. - PubMed
    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. - PubMed

LinkOut - more resources